Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients

MLA

Yu‐Hung Wang, et al. “Higher RUNX1 Expression Levels Are Associated with Worse Overall and Leukaemia‐free Survival in Myelodysplastic Syndrome Patients.” EJHaem, vol. 3, no. 4, Nov. 2022, pp. 1209–19. EBSCOhost, https://doi.org/10.1002/jha2.547.

APA

Yu‐Hung Wang, Chi‐Yuan Yao, Chien‐Chin Lin, Chi‐Ling Chen, Chia‐Lang Hsu, Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, & Hwei‐Fang Tien. (2022). Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients. EJHaem, 3(4), 1209–1219. https://doi.org/10.1002/jha2.547

Chicago

Yu‐Hung Wang, Chi‐Yuan Yao, Chien‐Chin Lin, Chi‐Ling Chen, Chia‐Lang Hsu, Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, and Hwei‐Fang Tien. 2022. “Higher RUNX1 Expression Levels Are Associated with Worse Overall and Leukaemia‐free Survival in Myelodysplastic Syndrome Patients.” EJHaem 3 (4): 1209–19. doi:10.1002/jha2.547.